PFD Capital Partners announced the closing of PFDSelect Medical Receivables 1018, LLC, the 17th special purpose entity in PFD’s 1000 Series focused on Personal Injury Medical Accounts Receivable financing. PFDSMR1018 launched on March 11, 2026, and closed to new investments on May 18, 2026, with participation from 99 investors, including 75 new investors, 34 referral-based investors, and 24 existing PFD investors who participated again. The release highlights PFD’s continued growth in medical receivables finance, its work helping medical service providers convert delayed receivables into working capital, and the company’s platform activity, including more than $2 billion in receivables managed, more than 1,000 portfolio transactions, over 250,000 patients assisted, and more than $360 million in capital raised or deployed.